Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series: World’s leading Event Organizer

Back

Clayton A. Dehn

Clayton A. Dehn

Sr VP Early Svc & Strategic Development,
Clinical Trials of Texas
USA

Biography

Clayton Dehn is the Sr. V.P., Early Phase Services and Strategic Development at Clinical Trials of Texas, Inc., a multitherapeutic research site based in San Antonio. He is a research physiologist with expertise in endocrine and metabolic disorders. He is the co-inventor of a process and substance for disturbing the inheritance pattern of ion-channelopathic disorders, and the sole author of the first publication cautioning against the risk of SGLT-inhibition inducing ketoacidosis in insulinopenic populations. In addition to serving on the editorial board of three peer-reviewed journals, he has also served by gubernatorial appointment on the Arizona Biomedical Research Commission

Research Interest

Clinical Research | Early signals of efficacy to streamline the drug development process | The metabolic syndrome constellation of disorders (obesity, diabetes, hypertension, dyslipidemia, NAFLD/NASH)